Alerts will be sent to your verified email
Verify EmailDLCL
|
Dr Lalchandani Labs
|
Gian Life Care
|
DhanvantriJeevan Rek
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.03 % | 14.94 % | 2.68 % |
|
5yr average Equity Multiplier
|
1.69 | 1.77 | 1.51 |
|
5yr Average Asset Turnover Ratio
|
0.43 | 0.42 | 1.22 |
|
5yr Avg Net Profit Margin
|
1.96 % | 16.86 % | -1.83 % |
|
Price to Book
|
0.0 | 0.43 | 0.9 |
|
P/E
|
19.67 | 0.0 | 73.4 |
|
5yr Avg Cash Conversion Cycle
|
103.23 Days | -716.89 Days | 30.84 Days |
|
Inventory Days
|
78.71 Days | 34.09 Days | 2.65 Days |
|
Days Receivable
|
408.23 Days | 299.97 Days | 28.6 Days |
|
Days Payable
|
262.63 Days | 546.3 Days | -1976.44 Days |
|
5yr Average Interest Coverage Ratio
|
3.16 | 5.74 | 7.8 |
|
5yr Avg ROCE
|
5.08 % | 21.51 % | -0.53 % |
|
5yr Avg Operating Profit Margin
|
14.13 % | 30.05 % | 2.35 % |
|
5 yr average Debt to Equity
|
0.48 | 0.25 | 0.0 |
|
5yr CAGR Net Profit
|
-16.1 % | n/a | n/a |
|
5yr Average Return on Assets
|
1.95 % | 8.84 % | -0.6 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
32.9 % | 30.17 % | 19.65 % |
|
Share Pledged by Promoters
|
0.0 | 65.08 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-27.88 % | -26.73 % | -0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dr Lalchandani Labs
|
Gian Life Care
|
DhanvantriJeevan Rek
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|